Literature DB >> 8931178

Control of epiglottic position in dogs: role of negative upper airway pressure.

T C Amis1, N O'Neill, T Van der Touw, A Brancatisano.   

Abstract

We investigated the influence of negative upper airway pressure (NUAP) on hyoepiglotticus and genioglossus muscle electromyographic (EMG) activity in anaesthetised (sodium pentobarbitone/ chloralose) dogs breathing via a tracheostomy. Changes in pressure were not transmitted through the entire upper airway, thus confirming airway occlusion during NUAP. When NUAP was applied at the larynx, peak inspiratory and tonic EMG activity of the genioglossus and HE both increased significantly (p < 0.05) and reached a plateau at NUAP of -10 to -20 cmH2O. Nasal NUAP at any level failed to influence either genioglossus or HE EMG activity. Following bilateral section of the internal branches of the superior laryngeal nerves (SLNin), resting levels of HE and genioglossus EMG activity decreased to virtually zero. Moreover, NUAP applied at the larynx now failed to recruit EMG activity for either muscle. These findings suggest active control of epiglottic position in dogs during NUAP.

Entities:  

Mesh:

Year:  1996        PMID: 8931178     DOI: 10.1016/0034-5687(96)00052-7

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  3 in total

1.  Simultaneous staphylectomy and unilateral arytenoid lateralization in dogs presenting for dyspnea: 23 cases (2010-2013).

Authors:  Ann E Heffernan; Jeffery J Biskup; Betty A Kramek; Greg M Anderson
Journal:  Can Vet J       Date:  2016-10       Impact factor: 1.008

2.  Epiglottic movements during breathing in humans.

Authors:  T C Amis; N O'Neill; E D Somma; J R Wheatley
Journal:  J Physiol       Date:  1998-10-01       Impact factor: 5.182

3.  Clinical Features and Outcome of Dogs with Epiglottic Retroversion With or Without Surgical Treatment: 24 Cases.

Authors:  S C Skerrett; J K McClaran; P R Fox; D Palma
Journal:  J Vet Intern Med       Date:  2015-10-08       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.